SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-20-000431
Filing Date
2020-03-30
Accepted
2020-03-30 12:08:44
Documents
9
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K correvio6k.htm 6-K 18823
2 ANNUAL INFORMATION FORM FOR THE FISCAL YEAR ENDED DECEMBER 31, 2019 ex991.htm EX-99.1 681206
3 AUDITED CONSOLIDATED FINANCIAL STATEMENTS FOR THE FISCAL YEAR ENDED DECEMBER 31, ex992.htm EX-99.2 485401
4 MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERA ex993.htm EX-99.3 244712
5 MATERIAL CHANGE REPORT AND NEWS RELEASE DATED MARCH 30. 2020 ex994.htm EX-99.1 119993
6 CONSENT OF KPMG LLP ex995.htm EX-99.5 5854
7 GRAPHIC image_001.jpg GRAPHIC 5930
8 GRAPHIC image_002.jpg GRAPHIC 4241
9 GRAPHIC kpmg.jpg GRAPHIC 3926
  Complete submission text file 0001279569-20-000431.txt   1577030
Mailing Address 6TH FLOOR 1441 CREEKSIDE DRIVE VANCOUVER A1 V6J 4S7
Business Address 6TH FLOOR 1441 CREEKSIDE DRIVE VANCOUVER A1 V6J 4S7 1-604-677-6905
Correvio Pharma Corp. (Filer) CIK: 0001036141 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-29338 | Film No.: 20755308
SIC: 2834 Pharmaceutical Preparations